Market Size in 2021 | Market Forecast in 2028 | CAGR (in %) | Base Year |
---|---|---|---|
USD 20.1 Billion | USD 70 Billion | 11% | 2021 |
FrequentlyAsked Questions
Rise in cases of diabetics owing to inactive lifestyle along with swift industrialization will steer diabetes care devices market size.
According to Zion market research report, the global Diabetes Care Devices Market accrued earnings worth approximately 50.1(USD Billion) in 2021 and is predicted to gain revenue of about 79.2(USD Billion) by 2028, is set to record a CAGR of nearly 6% over the period from 2022 to 2028.
North America will contribute sizably towards the global market revenue over the projected timeline. A massive increase in Diabetes Care Devices Market size in sub-continent over 2022-2028 can be due to rise in number of diabetics in North America.
The key industry participants leveraging business space include Terumo Corporation, Acon Laboratories, Inc., Abbott Laboratories, Dexcom, Inc., Novo Nordisk A/S, Johnson & Johnson, Bayer AG, Merck & Co., Inc., The Ypsomed Group, Roche Diagnostics Ltd., Becton, Dickinson and Company, Medtronic plc, ARKRAY, Inc., and Sanofi S.A.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed